Sanofi-Aventis settles US Medicaid fraud charges
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis has agreed to pay $95 million in a civil settlement with the US Department of Justice and the US Attorney's Office for the District of Massachusetts to resolve a Medicaid "best price" investigation involving one of its predecessor companies, Aventis Pharmaceutical Inc.